EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia and coexisting comorbidities
The current standard of care for patients with chronic lymphocytic leukaemia (CLL) and coexisting conditions is fixed duration chemoimmunotherapy or…
Test shown to improve accuracy in identifying precancerous pancreatic cysts
In a proof-of-concept study, an international scientific team led by Johns Hopkins Kimmel Cancer Center researchers has shown that a…
Recent Videos
-
ASCO GU 2019 VIDEO: Genitourinary Cancers Symposium Presscast
-
Nobel Prize awarded “for discovery of cancer therapy by inhibition of negative immune regulation”
-
-
Jury finds Monsanto liable in the first Roundup cancer trial – here’s what could happen next
-
Killer immunotherapy—fighting cancer with genetic engineering
-
-
-
-
-
FEATURED COURSE
New research gives hope in the fight against pancreatic cancer
Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas CNIO Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, is…
A simple text could make the difference between life and death
A Ph.D. researcher from the University of South Australia is testing whether smartphone text messages can encourage cancer patients to…
WE CAN HELP CONNECT YOU
